Company News
Jefferies Flags CVS Health, 29% Upside
Jefferies rates CVS Health a Buy with a $120 price target, implying 29% upside from the $92.92 close.
Management set an $8.44 per-share FY2027 earnings floor, backed by Aetna’s $2.4 billion Q2 adjuste
